Chiyoda Global Headquarters
Minato Mirai Grand Central Tower
4-6-2, Minatomirai, Nishi-ku,
Yokohama 220-8765, Japanwww.chiyodacorp.com/en

PRESS RELEASE
Sep 19, 2024

Chiyoda Corporation and the University of Tsukuba announce the Completion andOperation of an Advanced Cell Processing Facility (CPF) at the University ofTsukuba Hospital
Chiyoda Corporation (Chiyoda) is pleased to announce the completion of the Tsukuba Advanced Cell
Therapy Facility (TACT) in September 2024, for operation one month later, in a collaborative projectwith the University of Tsukuba and the University of Tsukuba Hospital.
As a pioneering engineering company, Chiyoda has over 60 years of experience, and successfullycompleted more than 630 projects, in the life science field. We commenced Joint Research andCommissioned Research (*1) with the University of Tsukuba and established the Tsukuba Stem Cell Lab(TSL) within the University of Tsukuba Industry-Academia Liaison Joint Research Center in 2020. This
collaborative venture combines Chiyoda’s accumulated technical expertise with the academic
knowledge of the University of Tsukuba to support the comprehensive development of foundational
technologies in the field of cell therapy, from basic research to societal implementation.
TACT utilizes the foundation of the collaborative innovation hub "Tsukuba Digital-Bio InternationalCenter" (*2) to develop manufacturing processes for cell therapy and other products. With the additionof TSL and our Subsidiary Office Research Park, Chiyoda now has three bases to expand our"Technical Consulting" (*3) services to establish manufacturing process conditions for cell therapy
products and evaluate cell characteristics, combining academia, medical institutions and businesses
from basic research to manufacturing development support. Chiyoda’s participation aims to establish
the manufacturing and technology of immune cells, derived from induced pluripotent stem cells, toserve as the foundation for the practical application of cancer immunotherapy research.
Through this project, we will continue ‘Enriching Society through Engineering Value’.

(*1) Joint Research and Commissioned ResearchA University of Tsukuba program to solve common academia and industry challenges. Companies allocate
research personnel and fund University of Tsukuba faculty members, and industry researchers collaborate on
joint research on an equal footing.
Joint Research and Commissioned Research | Headquarters for International Industry-University Collaboration
University of Tsukuba(*2) Tsukuba Digital-Bio International Center
Based on the ‘Creation of Collaborative Innovation Hubs’ program,, supported by the Japan Science andTechnology Agency (JST), to establish hubs that utilize bioresources and digital technologies in Tsukuba,
enabling interdisciplinary research to support the well-being of all generations and contribute to the realization ofa better society.

Internet Security by Zscaler (tsukubadigitalbio.jp)(*3) Technical Consulting
Chiyoda’s new service business providing strategic and technical solutions in the research and development,
manufacturing process development, and support for cutting-edge pharmaceuticals such as cell therapy. Theseproducts require different technologies and knowledge in terms of their pharmacological principles, evaluation
tests and manufacturing processes compared to conventional small molecule drugs. Chiyoda ensurescompliance with regulations and guidelines, while offering innovative solutions anticipating productcommercialization.

For further information, please contact:
Chiyoda Corporation
IR、PR＆Sustainability Advanced Section
Email: irpr@chiyodacorp.com
URL: https://www.chiyodacorp.com/en/contact/index.php